ALLIANCEBERNSTEIN L.P. - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$324,801
+12.5%
67,9500.0%0.00%
Q2 2023$288,788
+37.3%
67,950
+71.6%
0.00%
Q1 2023$210,276
-5.1%
39,600
+12.2%
0.00%
Q4 2022$221,684
-29.4%
35,300
+18.5%
0.00%
Q3 2022$314,000
+130.9%
29,800
+18.7%
0.00%
Q2 2022$136,000
-76.8%
25,100
+2.5%
0.00%
Q3 2021$585,00024,4880.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$11,316,00014.13%
Memorial Sloan Kettering Cancer Center 674,196$16,093,00010.03%
PFM Health Sciences, LP 4,092,309$88,176,0002.59%
CloudAlpha Capital Management Limited/Hong Kong 305,000$7,280,0002.15%
Monashee Investment Management LLC 449,377$10,727,0001.98%
Avidity Partners Management LP 2,474,067$59,056,0001.31%
Green Alpha Advisors, LLC 32,836$784,0000.54%
Tekla Capital Management LLC 699,377$15,621,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 200,000$4,774,0000.40%
FARALLON CAPITAL MANAGEMENT LLC 2,963,448$70,738,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders